LysoPC(18:2(9Z,12Z))

lipid

Lysophosphatidylcholine species altered in acute coronary syndrome, marking lipoprotein oxidation and inflammatory lipid-mediator activation.

Pathway placement

Cascade stepLipid retention & oxidation

Confidencemedium

RationaleLipid mediator; inversely correlates with atherosclerosis burden; involved in lipoprotein remodeling.

Also acts inVascular inflammation, Myocardial injury

Druggability

Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.

Specimen

Serum or plasma (EDTA to limit oxidation)

Collection tube

K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)

Method / principle

LC-MS/MS lipidomics (targeted or shotgun)

Reagent / substrate

Deuterated lipid-class internal standards; MS/MS transitions

Platform

LC-MS/MS

Turnaround · availability

Research · Research-only